Sposito Carlo Ferruccio Alvise

Associate Professor
Scientific-Disciplinary Sector
MEDS-06/A - General Surgery
Scientific-Disciplinary Group/Competition Sector
06/MEDS-06 - CHIRURGIA GENERALE

Contacts

Workplace

Via Venezian, 1 - Istituto Nazionale Tumori
20133 MILANO (MI)

Additional phone numbers
02 23903496
University email address
Research

Publications

  • Prediction of early recurrence as a marker of surgical futility in pancreatic adenocarcinoma / D. Citterio, M. Droz dit Busset, C. Sposito, M. Mazzola, S. Grandi, A. Zironda, G. Leoncini, N. Simonotti, C. Battiston, M. Flores, G. Ferrari, V. Mazzaferro. - In: SURGICAL ONCOLOGY. - ISSN 0960-7404. - 59:(2025 Apr), pp. 102208.1-102208.7. [10.1016/j.suronc.2025.102208]
  • Intention-to-Treat Analysis of Hepatic Resection for Liver Metastases from Uveal Melanoma: A Single-Center Experience / M. Maspero, I. Pezzoli, L. Di Guardo, M. Angi, S. Lo Dico, C. Sposito, C. Battiston, V. Mazzaferro. - In: ANNALS OF SURGICAL ONCOLOGY. - ISSN 1068-9265. - (2025). [Epub ahead of print] [10.1245/s10434-025-17115-0]
  • Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndrome / G. Berardi, A. Cucchetti, C. Sposito, F. Ratti, M. Nebbia, D.M. D'Souza, F. Pascual, E. Dogeas, S. Tohme, A. Vitale, F.E. D'Amico, R. Alessandris, V. Panetta, I. Simonelli, M. Colasanti, N. Russolillo, A. Moro, G. Fiorentini, M. Serenari, F. Rotellar, G. Zimitti, S. Famularo, T. Ivanics, F.G. Donando, D. Hoffman, E. Onkendi, Y. Essaji, T. Giuliani, S. Lopez Ben, C. Caula, G. Rompianesi, A. Chopra, M. Abu Hilal, G. Sapisochin, G. Torzilli, C. Corvera, A. Alseidi, S. Helton, R.I. Troisi, K. Simo, C. Conrad, M. Cescon, S. Cleary, D.C.H. Kwon, A. Ferrero, G.M. Ettorre, U. Cillo, D. Geller, D. Cherqui, P.E. Serrano, C. Ferrone, L. Aldrighetti, T.P. Kingham, V. Mazzaferro. - In: JHEP REPORTS. - ISSN 2589-5559. - 6:7(2024 Jul), pp. 101075.1-101075.10. [10.1016/j.jhepr.2024.101075]
  • A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study / M. Niger, F. Nichetti, L. Fornaro, C. Pircher, F. Morano, F. Palermo, L. Rimassa, T. Pressiani, R. Berardi, A.C. Gardini, E. Sperti, L. Salvatore, D. Melisi, F. Bergamo, S. Siena, S. Mosconi, R. Longarini, G. Arcangeli, S. Corallo, L. Delliponti, S. Tamberi, E. Fea, G. Brandi, I.G. Rapposelli, M. Salati, P. Baili, R. Miceli, S. Ljevar, I. Cavallo, E. Sottotetti, A. Martinetti, M.D.D. Busset, C. Sposito, M. Di Bartolomeo, F. Pietrantonio, F. de Braud, V. Mazzaferro. - In: BMC CANCER. - ISSN 1471-2407. - 24:1(2024 Apr 08), pp. 436.1-436.10. [10.1186/s12885-024-12225-6]
  • NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer / F. Nichetti, S. Rota, P. Ambrosini, C. Pircher, E. Gusmaroli, M. Droz Dit Busset, S. Pusceddu, C. Sposito, J. Coppa, F. Morano, F. Pietrantonio, M. Di Bartolomeo, L. Mariani, V. Mazzaferro, F. de Braud, M. Niger. - In: JAMA NETWORK OPEN. - ISSN 2574-3805. - 7:1(2024 Jan 02), pp. e2350756.1-e2350756.13. [10.1001/jamanetworkopen.2023.50756]